SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

20 Apr 2022 07:00

RNS Number : 6551I
Biome Technologies PLC
20 April 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

 

20 April 2022

 

 

Biome Technologies plc

 

("Biome", "the Company" or "the Group")

 

Trading Update

 

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today provides an unaudited Trading Update for the quarter ended 31 March 2022.

 

Group revenues for the quarter ended 31 March 2022 were in line with management expectations at £1.1m (Q1 2021: £1.4m).

 

Bioplastics Division

 

The division's revenues for Q1 were £1.0m (Q1 2021: £1.2m). Further substantial revenue growth from this division is anticipated during 2022 as some of the previously reported logistics issues clear and a number of important customer positions accelerate or move into a commercial phase.

 

Stanelco RF Technologies Division

 

Revenues in the RF Technologies division in Q1 were £0.1m (Q1 2021: £0.2m). The division has a strong orderbook, announced previously, that are currently in production and are expected to deliver revenue both in Q2 and into the second half of the year. A solid pipeline of opportunities from our target markets are under discussion and continued good order intake is encouraging.

 

Group Performance

 

The Group had a cash balance as at 31 March 2022 of £0.9m (31 March 2021: £1.6m). As at 19 April 2022, the Group had cash of £0.9m and no debt.

 

Group Outlook

 

The Board's view of the Group's performance remains in line with current market expectations.

 

 

-Ends-

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Rob Smith, Chief Financial Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Sales and Corporate Broking)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited ("Bioplastic") and Stanelco RF Technologies Limited ("RF Technologies").

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil- based polymers.

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

www.biometechnologiesplc.com www.biomebioplastics.com and www.thinkbioplastic.com www.stanelcorftechnologies.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKCBBABKDDQD
Date   Source Headline
11th Apr 20057:00 amRNSRe Agreement
7th Apr 20057:00 amRNSRe Agreement
6th Apr 200512:41 pmRNSAdditional Listing
24th Mar 20057:00 amRNSRe Contract
22nd Mar 20054:49 pmRNSAnnual Report and Accounts
21st Mar 20057:02 amRNSStatement on High Court
1st Mar 20057:01 amRNSUpdate re. trials with Asda
28th Feb 20057:00 amRNSFinal Results
23rd Feb 20054:45 pmRNSAdditional Listing
9th Feb 20053:16 pmRNSAgreement and Placing
8th Feb 20057:00 amRNSUpdate re. trials with Asda
31st Jan 20059:09 amRNSRe. Agreement
25th Jan 20057:00 amRNSDirectorate Change
17th Jan 200511:44 amRNSAdditional Listing
4th Jan 200511:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.